http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-20130100583-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_543ebcaa8a01acf74b1f40d3bb90c79d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4df3d9a4aaf4ae9a4fc959164867f013
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78d88933e3860dbe1a7c2e2c374cc923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92d2291bf5001dc0c06c379c1eda8f6
publicationDate 2015-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GR-20130100583-A
titleOfInvention MEDICINE FOR TREATMENT OF PSORIUM DISEASE
abstract Products containing losartan (potassium), or pharmaceutically acceptable salts thereof, or mixtures thereof for the manufacture of a medicament for the treatment of psoriatic disease, wherein said medicament is adapted in a unit dosage form 50 - 1.000 mg of losartan and potassium, depending on the amount of the active substance. eg in a formulation containing 50 qng of losartan active substance, potassium content 4. 24 mg (0. 108 mEq), in a formulation of 100 mg of losartan active substance, potassium content 8. 48 mg (0. 216 mEq) cc with a corresponding progressive increase in combination with the use of excipients: Microcrystalline cellulose (E 460), lactose monohydrate pregeiatinized starch magnesium stearate (E 572) hydroxypropyl cellulose (E 463) hypromellose (E 463). E 464) Carnauba wax (E 903), Titanium dioxide (E171) The administration of a Losartan Potassium active ingredient formulation at a dosage of 100 mg daily in psoriasis patients results in the disappearance of psoriasis. of the symptoms of the disease.
priorityDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454025817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239

Total number of triples: 27.